Large gap with delayed quotes
|
Last quote
12/15/2025
-
22:15:00
|
Bid
12/15/2025 -
21:59:59
|
Bid Volume |
Ask
12/15/2025 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
0.6631
-0.0559
(
-7.77% )
|
0.6603
|
1,000 |
0.6631
|
145,700 |
Analysis date: 12.12.2025
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 11.11.2025.
Interest
Weak
Weak
Two stars since 12.12.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 09.12.2025 at a price of 0.66.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 09.05.2025.
4wk Rel Perf
16.49%
16.49%
The four-week dividend-adjusted overperformance versus SP500 is 16.49%.
Sensibility
High
High
High, no change over 1 year.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.26%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 8.45%.
Mkt Cap in $bn
0.30
0.30
With a market capitalization <$2bn, AGILON HEALTH is considered a small-cap stock.
G/PE Ratio
6.26
6.26
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
-3.19
-3.19
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
19.94%
19.94%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
16
16
Over the last seven weeks, an average of 16 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
3
3
For 1% of index variation, the stock varies on average by 0.03%.
Correlation
0.01
0.01
Stock movements are totally independent of index variations.
Value at Risk
0.63
0.63
The value at risk is estimated at USD 0.63. The risk is therefore 87.94%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
26.10.2021
26.10.2021